A DNA vaccine against dolphin morbillivirus is immunogenic in bottlenose dolphins

Veterinary Immunology and Immunopathology

Volumn 120, Issue 3-4, 2007, Pages 260-266

  Vaughan, Kerrie ^a   Del Crew, Jason ^b   Hermanson, Gary ^c   Wloch, Mary K ^c   Riffenburgh, Robert H ^d   Smith, Cynthia R ^e   Van Bonn, William G ^e  

^a NATIONAL RESEARCH COUNCIL   (United States)

^b SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^c VICAL INC   (United States)

^d Space and Naval Warfare Systems Center Pacific   (United States)

^e Naval Command   (United States)

Author keywords

DNA vaccine and dolphin; Morbillivirus

Indexed keywords

DNA VACCINE; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOLPHIN; DRUG EFFICACY; DRUG SCREENING; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; INJECTION; INOCULATION; MALE; MEASLES; MEASLES VIRUS; NONHUMAN; VACCINATION;

AGING; ANIMALS; BOTTLE-NOSED DOLPHIN; FEMALE; IMMUNOGLOBULIN G; MALE; MORBILLIVIRUS; MORBILLIVIRUS INFECTIONS; TIME FACTORS; VACCINES, DNA;

ANIMALIA; DASHEEN MOSAIC VIRUS; DOLPHIN MORBILLIVIRUS; MAMMALIA; MORBILLIVIRUS; MUS; TURSIOPS; TURSIOPS TRUNCATUS;

EID: 35449007681     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.06.036     Document Type: Article

References (41)

1. Ada G., and Ramshaw I. DNA vaccination. Exp. Opin. Emerg. Drugs. 8 (2003) 27-35
2. Atabani S.F., Obeid O.E., Chargelegue D., Aaby P., Whittle H., and Steward M.W. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein using human sera from acute infection. J. Virol. 71 (1997) 7240-7245
3. Blair P.J., Kochel T.J., Raviprakash K., Guevara C., Salazar M., Wu S.J., Olson J.G., and Porter K.R. Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeys. Vaccine 24 (2006) 1427-1432
4. Blanchard M.T., Funke C., and Stott J.S. Lymphocyte profile of free-ranging dolphins (Tursiops truncatus) in Sarasota Bay, Florida. Proceedings of the International Association for Aquatic Animal Medicine (IAAAM). Waikoloa, Hawaii (2003)
5. Chaplin P.J., De Rose R., Boyle J.S., McWaters P., Kelly J., Tennet J., Lew A., and Scheerlinck J.P. Targeting improves the efficacy of DNA vaccines against Corynebacterium pseudotuberculosis in sheep. Infect. Immun. 67 (1999) 6434-6438
6. Davis H.L., McCluskie M.J., Gerin J.L., and Purcell R.H. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. 93 (1996) 7213-7218
7. De Rose R., McKenna R.V., Cobon G., Tennent J., Zakrzewski H., Gale K., Wood P.R., Scheerlinck J.P., and Willadsen P. Bm86 antigen induces a protective immune response against Boophilus microplus following DNA and protein vaccination in sheep. Vet. Immunol. Immunopath. 71 (1999) 151-160
8. De Rose R., Tennet J., McWaters P., Chaplin P.J., Wood P.R., Kimpton W., Cahill R., and Scheerlinck J.P. Efficacy of DNA vaccination by different routes of immunization in sheep. Vet. Immunol. Immunopath. 90 (2002) 55-63
9. de Swart R.L., Harder T.C., Ross P.S., Vos H.W., and Osterhaus A.D. Morbilliviruses and morbillivirus diseases of marine mammals. Infect. Agents. Dis. 4 (1995) 125-130
10. d'Oliveira C., Feenstra A., Vos H., Osterhaus A.D., Shiels B.R., Cornelissen A.W., and Jongejan F. Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems. Vaccine 15 (1997) 1796-1804
11. Domingo M., Ferrer L., Pumarola M., Marco A., Plana J., Kennedy S., Mcalisky M., and Rima B.K. Morbillivirus in dolphins. Nature 348 (1990) 21
12. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15 (1997) 617-648
13. Duignan P.J., Nielsen O., House C., Kovacs K., Duffy N., Early G., Sadove S., St.Aubin D.J., Rima B., and Geraci J.R. Epizoology of morbillivirus infection in harp, hooded and ringed seals from the Canadian arctic and western Atlantic. J. Wildl. Dis. 33 (1997) 7-19
14. Eichmann K., Braun D.G., and Krause R.M. Influence of genetic factors on the magnitude and the heterogeneity of the immune response in the rabbit. J. Exp. Med. 134 (1971) 48-65
15. Ertl O.T., Wenz D.C., Bouche F.B., Berbers G.A., and Muller C.P. Immunodominant domains of the measle virus hemagglutinin protein elicit a neutralizing human B cell response. Arch. Virol. 148 (2003) 2195-2206
16. Globerson A., and Effros R.B. Ageing of lymphocytes and lymphocytes in the aged. Immunol. Today 21 (2000) 515-521
17. Grubeck-Loebenstein B., and Wick G. The aging of the immune system. Adv. Immunol. 80 (2002) 243-284
18. Gurunathan S., Klinman D.M., and Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18 (2000) 927-974
19. Hall A.J. Morbilliviruses in marine mammals. Trends Microbiol. 3 (1995) 4-9
20. Lavi Y., Cahaner A., Pleban T., and Pitcovski J. Genetic variation in major histocompatibility complex class I alpha2 gene among broilers divergently selected for high or low early antibody response to Escherichia coli. Poult. Sci. 84 (2005) 1199-1208
21. Linton P.J., and Dorshkind K. Age-related changes in lymphocyte development and function. Nat. Immunol. 5 (2004) 133-139
22. Lipscome T.P., Schulman F.Y., Moffett D., and Kennedy S. Morbilliviral disease in Atlantic bottlenose dolphins (Tursiops truncatus) from the 1988-1989 epizootic. J. Wildl. Dis. 30 (1994) 567-571
23. Loehr B.I., Willson P., Babiuk L.A., and van Drunen Little-van den Hurk S. Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J. Virol. 74 (2000) 6077-6086
24. Mahy B.W.J., Barrett T., Evans S.A., Anderson E.C., and Bostock C.J. Characterization of seal morbillivirus. Nature, London 336 (1988) 115
25. Martinez X., Brandt C., Saddallah F., Tougne C., Barrios C., Wild F., Dougan G., Lambert P.H., and Siegrist C.A. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8726-8731
26. Partidos C.D., Salani F.B., Ripley J., and Steward M.W. Deconstructing the antigenic profile of a protective epitope from measles virus fusion protein using overlapping peptides. Vaccine 18 (1999) 321-324
27. Pavlenko M., Roos A.K., Lundqvist A., Palmborg A., Miller A.M., Ozenci V., Bergman B., Egevad L., Hellstrom M., Kiessling R., Masucci G., Wersall P., Nilsson S., and Pisa P. A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. Br. J. Cancer 91 (2004) 688-694
28. Prince A.M., Whalen R., and Brotman B. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine. 15 (1997) 916-919
29. Rhodes G.H. Vaccines (1993), Cold Spring Harbor Laboratory Press
30. Robinson H.L., Hunt L.A., and Webster R.G. Protection against lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11 (1993) 957-960
31. Sarzotti M., Dean T.A., Remington M.P., Ly C.D., Furth P.A., and Robbins D.S. Induction of cytotoxic T cell responses in newborn mice by DNA immunization. Vaccine 15 (1997) 795-797
32. Sciutto E., Martinez J.J., Huerta M., Avila R., Fragoso G., Villalobos N., de Aluja A., and Larralde C. Familial clustering of Taenia solium cysticercosis in the rural pigs of Mexico: hints of genetic determinants in innate and acquired resistance to infection. Vet. Parasitol. 116 (2003) 223-229
33. Sedegah M., Charoenvit Y., Aguiar J., Sacci J., Hedstrom R., Kumar S., Belmonte A., Lanar q.D.E., Jones T.R., Abot E., Druilhe P., Corradin G., Epstein J.E., Richie T.L., Carucci D.J., and Hoffman S.L. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Genes Immun. 5 (2004) 553-561
34. Smith C.R., Van Bonn W.G., Hermanson G., Wloch M., Hobart P., and Romano T.A. Administration of reporter gene plasmid vaccines to Atlantic Bottlenose dolphins, Tursiops truncatus. Proceedings of the International Association of Aquatic Animals Medicine (IAAAM). Portugal, Spain (2002)
35. Taubenberger J.K., Tsai M., Krafft A.E., Lichy J.H., Reid A.H., Schulman F.Y., and Lipscomb T.P. Two Morbilliviruses implicated in Bottlenose dolphin epizootics. Emerg. Inf. Dis. 2 (1996) 213-216
36. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., De Witt D.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.C., and Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259 (1993) 1745-1749
37. Van Bressem M.-F., Van Waerebeek K., Jepsen P.D., Raga J.A., Duignan P., Nielsen O., Di Beneditto A.P., Siciliano S., Ramos R., Kant W., Peddemors V., Kinoshita R., Ross P., Lopez-Fernandez A., Evans K., Crespo E., and Barrett T. An insight into the epidemiology of dolphin morbillivirus worldwide. Vet. Microbiol. 81 (2001) 287-304
38. van Drunen Littel-van den Hurk S., Braun R.P., Lewis P.J., Karvonen B.C., Baca-Estrada M.E., Snider M., McCartney D., Watts T., and Babiuk L.A. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79 (1998) 831-839
39. Visser I.K., Van, Bressem M.F., Barrett T., and Osterhaus A.D.M.E. Morbillivirus infections in aquatic mammals. Vet. Res. 24 (1993) 169-178
40. Vordermeier H.M., Cockle P.J., Whelan A.O., Rhodes S., Chambers M.A., Clifford D., Huygen K., Tascon R., Lowrie D., Colston M.J., and Hewinson R.G. Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test. Vaccine 19 (2001) 1246-1255
41. Wedlock D.N., Skinner M.A., Parlane N.A., Vordermeier H.M., Hewinson R.G., de Lisle G.W., and Buddle B.M. Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis. Tuberculosis 83 (2003) 339-349